Newport Trust Company LLC Sells 24,989 Shares of Humana Inc. $HUM

Newport Trust Company LLC decreased its position in shares of Humana Inc. (NYSE:HUM) by 2.3% during the third quarter, according to its most recent filing with the SEC. The firm owned 1,066,534 shares of the insurance provider’s stock after selling 24,989 shares during the period. Humana comprises about 0.6% of Newport Trust Company LLC’s holdings, making the stock its 26th largest holding. Newport Trust Company LLC owned about 0.89% of Humana worth $277,480,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in Humana by 1.6% in the second quarter. Vanguard Group Inc. now owns 14,199,096 shares of the insurance provider’s stock worth $3,471,395,000 after purchasing an additional 226,224 shares during the period. Dodge & Cox boosted its holdings in shares of Humana by 5.6% during the 2nd quarter. Dodge & Cox now owns 11,352,920 shares of the insurance provider’s stock valued at $2,775,562,000 after buying an additional 597,705 shares in the last quarter. State Street Corp grew its position in shares of Humana by 1.1% in the 2nd quarter. State Street Corp now owns 5,377,390 shares of the insurance provider’s stock worth $1,319,334,000 after buying an additional 58,094 shares during the period. Pzena Investment Management LLC increased its stake in shares of Humana by 6.5% in the 2nd quarter. Pzena Investment Management LLC now owns 4,076,667 shares of the insurance provider’s stock worth $996,664,000 after acquiring an additional 247,744 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its position in Humana by 273.2% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,488,261 shares of the insurance provider’s stock valued at $907,541,000 after acquiring an additional 2,553,509 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Down 0.2%

Humana stock opened at $265.68 on Friday. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $315.35. The stock has a fifty day simple moving average of $258.26 and a two-hundred day simple moving average of $264.66. The company has a current ratio of 2.02, a quick ratio of 2.02 and a debt-to-equity ratio of 0.68. The firm has a market cap of $31.95 billion, a price-to-earnings ratio of 24.90, a PEG ratio of 2.19 and a beta of 0.45.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, beating the consensus estimate of $2.95 by $0.29. Humana had a return on equity of 12.86% and a net margin of 1.02%.The company had revenue of $32.65 billion for the quarter, compared to analysts’ expectations of $31.99 billion. During the same period last year, the firm posted $4.16 earnings per share. Humana’s revenue was up 11.1% compared to the same quarter last year. Equities analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be paid a $0.885 dividend. The ex-dividend date is Friday, December 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.3%. Humana’s payout ratio is currently 33.18%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. Wells Fargo & Company cut shares of Humana from an “overweight” rating to a “cautious” rating in a report on Wednesday, January 7th. Barclays restated an “underperformer” rating on shares of Humana in a research note on Monday, January 5th. Bank of America lifted their price objective on Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a research note on Friday, October 10th. Truist Financial cut their target price on Humana from $300.00 to $285.00 and set a “hold” rating on the stock in a research note on Monday, November 10th. Finally, Morgan Stanley reaffirmed an “underperform” rating on shares of Humana in a research report on Thursday, December 18th. Eight investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and five have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $293.37.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.